Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Annales de Dermatologie et de Vénéréologie - FMC ; 2(8):A294-5, 2022.
Article in English | PubMed Central | ID: covidwho-2158834

ABSTRACT

Introduction: La pandémie à SARS-CoV-2 a été source de nombreuses questions quant à l'impact de l'infection sur les dermatoses inflammatoires chroniques, et de l'impact des traitements de ces dermatoses sur la sévérité de l'infection. Le registre international Chi-PsoCov (enfants psoriasique souffrant de psoriasis et ayant développé une infection à SARS-CoV-2) a permis de montrer que les biothérapies n'augmentaient pas le risque de formes sévères de COVID-19 chez les enfants atteints de psoriasis. Par ailleurs, il était montré que le COVID-19 était responsable du développement de psoriasis de novo ou de l'aggravation d'un psoriasis connu chez certains enfants.Dans cette partie du travail nous nous sommes concentrés sur les enfants ayant développé une poussée de psoriasis après l'infection : aspects phénotypiques des poussées, et recherche de facteurs de risque liés à la maladie, au psoriasis, ou aux traitements, associés à l'aggravation du psoriasis après l'infection. Matériel et méthodes: Les données ont été collectées de février 2021 à mai 2022 en provenance de 14 pays. Les enfants étaient inclus s'ils avaient moins de 18 ans, un antécédent de psoriasis ou psoriasis apparu dans le moins suivant l'infection COVID-19, et avaient été infectés par le SARS-CoV-2 avec ou sans symptômes. Les enfants ayant développé un psoriasis de novo étaient exclus de cette étude. Résultats: Sur les 152 inclusions du registre Chi-PsoCov, dix enfants ont développé un psoriasis dans le mois suivant l'infection et n'ont pas été retenus dans ce travail. L'analyse a porté sur 135 enfants ayant développé 142 COVID-19. Le psoriasis était stable dans 120 cas (84,5 %) et s'aggravait dans le mois suivant l'infection dans 22 cas (15,5 %).Dans 20 cas, lors de la poussée, le phénotype était inchangé, et dans 2 cas, il y avait un changement de phénotype : psoriasis en plaques en psoriasis en gouttes (n = 1) ou inversé (n = 1).Ni les caractéristiques démographiques, ni les aspects du psoriasis (notamment psoriasis actif vs en rémission), ni la sévérité de l'infection à SARS-CoV-2 n'étaient associés à des poussées de psoriasis. Seule l'utilisation de traitements systémiques du psoriasis, conventionnels ou biothérapies, lors de l'infection semblait protectrice de la survenue de poussées (50,0 % dans le groupe stable vs 27,3 % dans le groupe poussées, p = 0,049). Discussion: L'infection à SARS-CoV-2 est responsable dans environ 15 % des cas de poussées de psoriasis. Dans la grande majorité des cas, le phénotype précédent l'infection est conservé. Ces poussées ne sont pas associées à la sévérité du psoriasis, de l'infection ou autres paramètre cliniques. Seuls les traitements systémiques semblent réduire ce risque, probablement en « contrôlant » la poussée. Il est possible qu'une susceptibilité d'ordre génétique, non explorée ici, explique aussi cette susceptibilité à l'infection.

3.
European Psychiatry ; 65(Supplement 1):S673, 2022.
Article in English | EMBASE | ID: covidwho-2154145

ABSTRACT

Introduction: PTSD is a chronic, debilitating condition with limited treatment efficacy. Accessing traumatic memories often leads to overwhelming distress, impacting treatment process. Current approved pharmacological treatments have exhibited small to moderate effects when compared with placebo. Evidence suggests 3,4,-methylene-dioxymethamphetamine(MDMA)-assisted psychotherapy as a viable option for refractory PTSD. Objective(s): Comprehensive review of early clinical research, proposed mechanisms, safety and emerging therapeutic models. Method(s): Eligible studies will be identified through strategic search of MEDLINE. Result(s): Pre-clinical and imaging studies suggest memory reconsolidation and fear extinction as candidate psychological and neurological mechanisms, involving MDMA's combined effects of increasing serotonergic activity, as well the release of oxytocin and brain-derived neurotrophic factor in key memory and emotional circuits. Resulting reduction in amygdala and insula activation and increasing connectivity between the amygdala and hippocampus may create a tolerance window of neuroplasticity for emotional engagement and reprocessing of traumatic memories during psychotherapy. Early clinical trials report impressive and durable reduction in PTSD symptoms, with a safety profile comparable to that of SSRIs. A recently completed randomized, double-blind, placebocontrolled phase 3 trial reported full remission of PTSD symptoms in 67% of patients at 2 months, with no increase in suicidality, cardiovascular events or abuse behavior. Emerging treatment models underline the importance of unmedicated therapeutic sessions for preparation for the experience and subsequent integration as essential for full benefit and safety of the clinical context. Conclusion(s): The psychological impact associated with the COVID-19 pandemic is an reminder of the emotional and economic burden associated with PTSD. MDMA-assisted therapy may be a breakthrough approach meriting further multidisciplinary investment and clinical research.

5.
Sustainability ; 14(21), 2022.
Article in English | Web of Science | ID: covidwho-2123811

ABSTRACT

Burnout is a major concern for the scientific and educational community, as it leads to harmful consequences, both at a personal and organizational level. Several studies showed that burnout is influenced by multiple factors, including organizational climate and work-family conflict. However, studies analyzing these three variables together in the educational sector are scarce. Thus, this study aimed to analyze whether the organizational climate influenced burnout through work-family conflict. We collected data in two-time points with 253 teachers. The results showed that only the organizational climate dimensions of involvement, control, autonomy, task orientation, and physical comfort were associated with burnout. Plus, only the physical comfort and autonomy climates significantly reduced burnout via the decreases in work-family conflict. Thus, these organizational climates' dimensions seem to be essential factors to reduce not only work-family conflict but also burnout in the educational sector. This study tested the mediating role of work-family conflict on the link between organizational climate and burnout, with a group of teachers. Additionally, the data was collected during the pandemic crisis of COVID-19.

6.
2022 17th Iberian Conference on Information Systems and Technologies (Cisti) ; 2022.
Article in Spanish | Web of Science | ID: covidwho-2084114

ABSTRACT

The increase in COVID-19 infections due to the appearance of new variants causes serious health problems in the population. Although the majority of those infected have no symptoms, approximately 19% will require oxygen therapy for respiratory support, either by invasive or non-invasive ventilation. The high costs of this equipment mean that hospitals in developing countries have a limited supply of such equipment. Therefore, this paper presents the redesign, simulation, fabrication, and evaluation of a CPAP device that was developed in Europe but has now been replicated in Latin America. It starts with the analysis of the device's original design and through exploratory techniques and computer simulation the materials, parts, and assembly are determined. Functional tests validate that a prototype similar to the original was obtained that will provide noninvasive positive air pressure that keeps patients' airways open.

7.
European psychiatry : the journal of the Association of European Psychiatrists ; 65(Suppl 1):S673-S673, 2022.
Article in English | EuropePMC | ID: covidwho-2073622

ABSTRACT

Introduction PTSD is a chronic, debilitating condition with limited treatment efficacy. Accessing traumatic memories often leads to overwhelming distress, impacting treatment process. Current approved pharmacological treatments have exhibited small to moderate effects when compared with placebo. Evidence suggests 3,4,-methylene-dioxymethamphetamine(MDMA)-assisted psychotherapy as a viable option for refractory PTSD. Objectives Comprehensive review of early clinical research, proposed mechanisms, safety and emerging therapeutic models. Methods Eligible studies will be identified through strategic search of MEDLINE. Results Pre-clinical and imaging studies suggest memory reconsolidation and fear extinction as candidate psychological and neurological mechanisms, involving MDMA’s combined effects of increasing serotonergic activity, as well the release of oxytocin and brain-derived neurotrophic factor in key memory and emotional circuits. Resulting reduction in amygdala and insula activation and increasing connectivity between the amygdala and hippocampus may create a “tolerance window” of neuroplasticity for emotional engagement and reprocessing of traumatic memories during psychotherapy. Early clinical trials report impressive and durable reduction in PTSD symptoms, with a safety profile comparable to that of SSRIs. A recently completed randomized, double-blind, placebo-controlled phase 3 trial reported full remission of PTSD symptoms in 67% of patients at 2 months, with no increase in suicidality, cardiovascular events or abuse behavior. Emerging treatment models underline the importance of unmedicated therapeutic sessions for preparation for the experience and subsequent integration as essential for full benefit and safety of the clinical context. Conclusions The psychological impact associated with the COVID-19 pandemic is an reminder of the emotional and economic burden associated with PTSD. MDMA-assisted therapy may be a breakthrough approach meriting further multidisciplinary investment and clinical research. Disclosure No significant relationships.

8.
FEBS Open Bio ; 12:326-327, 2022.
Article in English | EMBASE | ID: covidwho-1976654

ABSTRACT

SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral Mpro is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N- and C-terminus. The lack of structural information for intermediary forms of Mpro is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 Mpro. For the immature form, we show that extra N-terminal residues caused conformational changes in the positioning of domainthree over the active site, hampering the dimerization and diminishing its activity. We propose that this form preludes the cis and trans-cleavage of N-terminal residues. Using fragment screening, we probe new cavities in this form which can be used to guide therapeutic development. Furthermore, we characterized a serine site-directed mutant of the Mpro bound to its endogenous Nand C-terminal residues during dimeric association stage of the maturation process. We suggest this form is a transitional state during the C-terminal trans-cleavage. This data sheds light in the structural modifications of the SARS-CoV-2 main protease during its self-maturation process.

9.
17th Iberian Conference on Information Systems and Technologies, CISTI 2022 ; 2022-June, 2022.
Article in Spanish | Scopus | ID: covidwho-1975657

ABSTRACT

The increase in COVID-19 infections due to the appearance of new variants causes serious health problems in the population. Although the majority of those infected have no symptoms, approximately 19% will require oxygen therapy for respiratory support, either by invasive or non-invasive ventilation. The high costs of this equipment mean that hospitals in developing countries have a limited supply of such equipment. Therefore, this paper presents the redesign, simulation, fabrication, and evaluation of a CPAP device that was developed in Europe but has now been replicated in Latin America. It starts with the analysis of the device’s original design and through exploratory techniques and computer simulation the materials, parts, and assembly are determined. Functional tests validate that a prototype similar to the original was obtained that will provide noninvasive positive air pressure that keeps patients' airways open. © 2022 IEEE Computer Society. All rights reserved.

10.
J Dent Res ; 101(9): 1015-1024, 2022 08.
Article in English | MEDLINE | ID: covidwho-1752997

ABSTRACT

Oral tissue regeneration following chronic diseases and injuries is limited by the natural endogenous wound-healing process. Current regenerative approaches implement exogenous systems, including stem cells, scaffolds, growth factors, and plasmid DNA/viral vectors, that induce variable clinical outcomes. An innovative approach that is safe, effective, and inexpensive is needed. The lipid nanoparticle-encapsulated nucleoside-modified messenger RNA (mRNA) platform has proven to be a successful vaccine modality against coronavirus disease 2019, demonstrating safety and high efficacy in humans. The same fundamental technology platform could be applied to facilitate the development of mRNA-based regenerative therapy. While the platform has not yet been studied in the field of oral tissue regeneration, mRNA therapeutics encoding growth factors have been evaluated and demonstrated promising findings in various models of soft and hard tissue regeneration such as myocardial infarction, diabetic wound healing, and calvarial and femoral bone defects. Because restoration of both soft and hard tissues is crucial to oral tissue physiology, this new therapeutic modality may help to overcome challenges associated with the reconstruction of the unique and complex architecture of oral tissues. This review discusses mRNA therapeutics with an emphasis on findings and lessons in different regenerative animal models, and it speculates how we can apply mRNA-based platforms for oral tissue regeneration.


Subject(s)
COVID-19 , Tissue Engineering , Animals , Bone Regeneration/genetics , Humans , Intercellular Signaling Peptides and Proteins , Liposomes , Nanoparticles , RNA, Messenger , Technology , Wound Healing/genetics
11.
14th International Conference on Theory and Practice of Electronic Governance, ICEGOV 2021 ; : 444-449, 2021.
Article in English | Scopus | ID: covidwho-1649701

ABSTRACT

This article aims to identify which European countries have been developed applications as an e-government service to control the COVID-19 pandemic. As a starting point, we use official data from the European Council to map countries that have at some point implemented or developed applications to combat the pandemic. In addition, we have identified the main functionalities and categories of the applications in contact tracking, medical reports, self-diagnosis, health information, exposure detection, quarantine application, route tracking, scientific and educational research. The methodology is based on an exploratory study, providing a qualitative method of analysis. First, we analyse whether applications are available for download on official websites as well as whether they are present on government social networks and, in addition, identifying the origin of applications categorized as government, private or multi-stakeholders. We concluded that 63% of developed applications are in the category of ' contact tracking ', followed by' medical report 'which corresponds to 15%. However, the category 'root tracking' corresponds to only 2% due to the data protection implications of the users. Thus, we found that although most applications had government support in their elaboration, they were not available for download on the official websites, so that, in the context of this investigation, they could not be considered as an e-government tools, and that data protection and privacy has had a negative impact on the development of this kind of solution, which implies the limitation of the applications functionalities. © 2021 ACM.

12.
J Endocrinol Invest ; 45(4): 875-882, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1520534

ABSTRACT

BACKGROUND: As COVID-19 became a pandemic, the urgent need to find an effective treatment vaccine has been a major objective. Vaccines contain adjuvants which are not exempt from adverse effects and can trigger the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is very little information about autoimmune endocrine disease and the ASIA after the use of mRNA-based SARS-CoV2 vaccination. CASE SERIES: We report three cases and also review the literature showing that the thyroid gland can be involved in the ASIA induced by the mRNA-based SARS-CoV2 vaccination. We present the first case to date of silent thyroiditis described in the context of SARS-CoV2 vaccination with Pfizer/BioNTech. Also, we discuss the first subacute thyroiditis in the context of SARS-CoV2 vaccination with the Moderna's vaccine. Finally, we provide another case to be added to existing evidence on Graves' disease occurring post-vaccination with the Pfizer/BioNTech vaccine. DISCUSSION: Adjuvants play an important role in vaccines. Their ability to increase the immunogenicity of the active ingredient is necessary to achieve the desired immune response. Both the Moderna and the Pfizer/BioNTech vaccines use mRNA coding for the SARS-CoV2 S protein enhanced by adjuvants. In addition, the cross-reactivity between SARS-CoV2 and thyroid antigens has been reported. This would explain, at least, some of the autoimmune/inflammatory reactions produced during and after SARS-CoV2 infection and vaccination. CONCLUSION: The autoimmune/inflammatory syndrome induced by adjuvants involving the thyroid could be an adverse effect of SARS-CoV2 vaccination and could be underdiagnosed.


Subject(s)
COVID-19 Vaccines/adverse effects , Graves Disease/etiology , Thyroid Gland/immunology , Thyroiditis/etiology , Vaccination/adverse effects , Adult , COVID-19 Vaccines/immunology , Female , Graves Disease/immunology , Humans , Male , Thyroiditis/immunology
13.
J Mol Biol ; 433(18): 167118, 2021 09 03.
Article in English | MEDLINE | ID: covidwho-1281466

ABSTRACT

SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral Mpro is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of Mpro is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 Mpro. For the immature form, we show that extra N-terminal residues caused conformational changes in the positioning of domain-three over the active site, hampering the dimerization and diminishing its activity. We propose that this form preludes the cis and trans-cleavage of N-terminal residues. Using fragment screening, we probe new cavities in this form which can be used to guide therapeutic development. Furthermore, we characterized a serine site-directed mutant of the Mpro bound to its endogenous N and C-terminal residues during dimeric association stage of the maturation process. We suggest this form is a transitional state during the C-terminal trans-cleavage. This data sheds light in the structural modifications of the SARS-CoV-2 main protease during its self-maturation process.


Subject(s)
Peptide Hydrolases/chemistry , Peptide Hydrolases/metabolism , SARS-CoV-2/metabolism , Viral Proteins/chemistry , Viral Proteins/metabolism , Catalytic Domain/physiology , Crystallography, X-Ray/methods , Dimerization , Humans
SELECTION OF CITATIONS
SEARCH DETAIL